Advice

Following an abbreviated submission

choriogonadotropin alfa 250 mcg/0.5 ml pre-filled syringe (Ovitrelle) is accepted for use in NHS Scotland for the treatment of anovulatory or oligo-ovulatory women, where the use of this preparation is appropriate.

Unlike the vial formulation available previously it does not require reconstitution, and the cost per dose is the same.

This replaces advice previously issued by the Scottish Medicines Consortium for Ovitrelle in May 2006 following a non-submission.

Download detailed advice29KB (PDF)

Download

Medicine details

Medicine name:
choriogonadotropin alfa 250 mcg/0.5 ml pre-filled syringe (Ovitrelle)
SMC ID:
264/06
Indication:
Anovulatory or oligo-ovulatory women
Pharmaceutical company
Serono Ltd
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Accepted
Date advice published
09 October 2006